Longitude Capital Partners III, LLC - Insider Trading & Ownership

Entity
Company
Location
800 El Camino, Suite 220, Menlo Park, California
Summary
The estimated value of insider holdings of Longitude Capital Partners III, LLC is at least $70.1M dollars as of April 29, 2022. Longitude Capital Partners III, LLC is the 10%+ Owner of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $54.7M. Longitude Capital Partners III, LLC is the 10%+ Owner of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. (INZY) stock worth about $14.9M. Longitude Capital Partners III, LLC is the 10%+ Owner of Sierra Oncology, Inc. and owns shares of Sierra Oncology, Inc. stock worth about $441K.
All Insider Reports
All Insider Reports

Ownership of Longitude Capital Partners III, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRML Tourmaline Bio, Inc. 10%+ Owner $54.7M May 11, 2021
INZY Inozyme Pharma, Inc. 10%+ Owner $14.9M Apr 19, 2022
SRRA Sierra Oncology, Inc. 10%+ Owner $441K Apr 27, 2022

Insider Transactions Reported by Longitude Capital Partners III, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.